Skip to main content
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1964 Feb;36(4):259–267.

Fate of Streptococcal M Protein After Exposure to Plasmin and Human Leukocytes **

Fred S Kantor
PMCID: PMC2604557  PMID: 14119861

Full text

PDF
261

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARNETT E. V., BARON S. An activator of plasminogen produced by cell culture. Proc Soc Exp Biol Med. 1959 Nov;102:308–311. doi: 10.3181/00379727-102-25229. [DOI] [PubMed] [Google Scholar]
  2. COHN Z. A., HIRSCH J. G. The isolation and properties of the specific cytoplasmic granules of rabbit polymorphonuclear leucocytes. J Exp Med. 1960 Dec 1;112:983–1004. doi: 10.1084/jem.112.6.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. FISHMAN M. Antibody formation in vitro. J Exp Med. 1961 Dec 1;114:837–856. doi: 10.1084/jem.114.6.837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. GILL F. A. A review of past attempts and present concepts of producing streptococcal immunity in humans. Q Bull Northwest Univ Med Sch. 1960;34:326–339. [PMC free article] [PubMed] [Google Scholar]
  5. KLINE D. L. Studies on the purification and activation of plasminogen (profibrinolysin). Yale J Biol Med. 1954 Apr;26(5):365–371. [PMC free article] [PubMed] [Google Scholar]
  6. LANCEFIELD R. C. Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test. J Exp Med. 1957 Oct 1;106(4):525–544. doi: 10.1084/jem.106.4.525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. LANCEFIELD R. C., PERLMANN G. E. Preparation and properties of type-specific M antigen isolated from a group A, type 1 hemolytic streptococcus. J Exp Med. 1952 Jul;96(1):71–82. doi: 10.1084/jem.96.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. LANCEFIELD R. C. Persistence of type-specific antibodies in man following infection with group A streptococci. J Exp Med. 1959 Aug 1;110(2):271–292. doi: 10.1084/jem.110.2.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. RIGGS J. L., SEIWALD R. J., BURCKHALTER J. H., DOWNS C. M., METCALF T. G. Isothiocyanate compounds as fluorescent labeling agents for immune serum. Am J Pathol. 1958 Nov-Dec;34(6):1081–1097. [PMC free article] [PubMed] [Google Scholar]
  10. STOLLERMAN G. H., EKSTEDT R. Long chain formation by strains of group A streptococci in the presence of homologous antiserum: a type-specific reaction. J Exp Med. 1957 Sep 1;106(3):345–356. doi: 10.1084/jem.106.3.345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Swift H. F., Wilson A. T., Lancefield R. C. TYPING GROUP A HEMOLYTIC STREPTOCOCCI BY M PRECIPITIN REACTIONS IN CAPILLARY PIPETTES. J Exp Med. 1943 Aug 1;78(2):127–133. doi: 10.1084/jem.78.2.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. WILSON A. T., WILEY G. G., BRUNO P. Fate of non-virulent group A streptococci phagocytized by human and mouse neutrophils. J Exp Med. 1957 Dec 1;106(6):777–786. doi: 10.1084/jem.106.6.777. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES